Holding(s) in Company

RNS Number : 4838Q
GlaxoSmithKline PLC
03 August 2010
 



 

Financial Services Authority

GlaxoSmithKline plc received on 2 August 2010 from Legal & General Group plc a notification of interests in GlaxoSmithKline plc Ordinary shares of 25 pence each, dated on 2 August 2010.  This notice is given in accordance with DTR 5.8.12.

 

Financial Services Authority

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

 

GlaxoSmithKline plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 


An event changing the breakdown of voting rights


 

Other (please specify):

 



3. Full name of person(s) subject to the
notification obligation:

Legal & General Group Plc (L&G)

4. Full name of shareholder(s)
 (if different from 3.):

Legal & General Assurance (Pensions Management) Limited (PMC)

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:

 

30 July 2010

6. Date on which issuer notified:

02 August 2010

7. Threshold(s) that is/are crossed or
reached:

 

 From 4% to 3%



 

8. Notified details:

 

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

 

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Indirect

Direct

Indirect

Ordinary 25p

 234,245,526

 

(As on 21/08/2009)

 207,179,146

 207,179,146


3.98%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

 

Expiration
date

 

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

 

 

Exercise price

 

Expiration date

 

Exercise/
Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

 207,179,146

 

3.98%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)


Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) 


Legal & General Investment Management Limited (Indirect) (LGIM)


Legal & General Group Plc (Direct) (L&G) ( 207,179,146 - 3.98%=LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) ( 173,376,830 - 3.33%= PMC) 

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited  (PMC) ( 173,376,830 - 3.33%= PMC) 

Legal & General Assurance Society Limited  (LGAS & LGPL)


Legal & General Pensions Limited (Direct)  (LGPL)


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:

Notification using the total voting rights figure of  5,192,618,078

14. Contact name:

Wayne Powell (LGIM)

15. Contact telephone number:

020 3124 3851

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPJMRTMBTMBFM

Companies

GSK (GSK)
UK 100

Latest directors dealings